Comparison between intramuscular and intravenous regimen of magnesium sulfate in management of severe preeclampsia and eclampsia

Vaibhav Kanti, Abhilasha Gupta, Shikha Seth, Mona Bajaj, Sunil Kumar, Mukeshvir Singh

Abstract


Background: Objective of current study was to compare between intramuscular (IM) and intravenous (IV) magnesium sulfate regimen in terms of efficacy, side effects, maternal and fetal outcome.

Methods: A prospective study was performed on 82 patients from September 2008 to January 2010 and comparison was made between IV and IM group, each group consisting of 17 patients of eclampsia and 24 patients of severe preeclampsia. IV group received continuous IV magnesium sulfate (IV MgSO4) consisting of 4gm of loading dose, administered over 15 minutes followed by maintenance dose of 2gm/hour. The IM group received intramuscular magnesium sulfate (IM MgSO4) according to Pritchard regimen.

Results: Recurrence of convulsion in was found in 1/17 (5.88%) of eclamptic patients in IV and 1/17 (5.88%) in IM group which is statistically not significant (P = 1).There was no occurrence of convulsion in any of the cases having severe eclampsia in either group. There was statistically no significant difference in maternal death between the two groups   (IM = 1/41(2.43%) and no mortality in IV group, P = 0.314). Statistically higher incidence (P = 0.034) of sign of impending toxicity such as loss of patellar reflex was seen in IM group as compared to IV group. Other signs of toxicity such as oliguria, respiratory rate depression though more in IM group, were statistically insignificant. There were no significant differences in other measures of serious maternal morbidity, in perinatal morbidity or mortality.

Conclusions: Both the groups are comparable in terms of control and prevention of recurrence of convulsions, maternal and perinatal morbidity and mortality. 


Keywords


Eclampsia, Severe preeclampsia, IV, IM, Magnesium sulfate

Full Text:

PDF

References


Bhargava A, Pant R, Chutani I, Singh SR. Accelerated recovery from eclampsia. J Obstet Gynecol India. 2006;56:402-5.

Seth S, Nagrath A, Singh DK. Comparison of low dose, single loading dose and standard Pritchard regimen of magnesium sulphate in ante-partum eclampsia. Anatol J Obstet Gynecol. 2010;1(1):1-4.

World Health Organization. Maternal mortality: fact sheet N°348", 2014. Available at: http://www.who.int/mediacentre/factsheets/fs348/en/. Accessed 20 June 2014.

Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97:533-8.

No Author. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345(8963):1455-63.

Pritchard JA, Cunningham, FG Pritchard SA. The parkland memorial hospital protocol for treatment of eclampsia evaluation of 245 cases. Am J Obstet Gynecol. 1984:148(7);951-63.

Ekele BA, Badung SL. Is serum magnesium estimate necessary in patients with eclampsia on magnesium sulphate? Afr J Reprod Health. 2005 Apr;9(1):128-32

Singh VK, Pandey K. Study of 80 patients with eclampsia. J Obstet Gynaecol India. 1992;43(4):547-61.

Sibai BM, Graham JM, McCubbin JH. A comparison of IV and IM magnesium sulphate regimens in preeclampsia. Am J Obstet Gynecol. 1984;150:728-33.

Agarwal S, Dhall K, Bhatia K. Epidemiologic IV of eclampsia. J Obstet Gynaecol India. 1983;33:83.

Latika Sahu, Shubhra Singh, Anjali Tempe, B. C. Koner. A randomized comparative study between low-dose magnesium sulphate and standard dose regimen for management of eclampsia. Int J Reprod Contracept Obstet Gynecol. 2014;3(1):79-86.

Bangal VB, Purushottam A. Giri, Satyajit P. Gavhane. A study to compare the efficacy of low dose magnesium sulphate regime with Pritchard regime in eclampsia. Int J Biomed Adv Res. 2012;3(1):53-7.

Coetzee EJ, Dommisse J, Anthony JA. Randomized controlled trial of IV magnesium sulphate versus placebo in the management of women with severe preeclampsia. S Afr Med J. 1994 Sep;84(9):607-10.

Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia - eclampsia. Am J Obstet Gynecol. 1990;162(5):1141-5.

Duley L. The Eclampsia Trial collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia trial. Lancet. 1995;345:1455-63.

Chinayon P. Clinical management and outcome of eclampsia at Rajavithi Hospital. J Med Assoc Thai. 1998;81(8):579-85.

Chissell S, Botha JH, Moodley J, McFadyen L. IV and IM magnesium sulphate regimens in severe preeclampsia. S Afr Med J. 1994 Sep;84(9):607-10.

Sardesai S, Maira S, Patil A. Low dose magnesium sulphate therapy for eclampsia and imminent eclampsia - regimen tailored for Indian women. J Obstet Gynecol India. 2003;53(6):546-50.

Joydeb Roy Chowdhury, Snehamay Chaudhuri, Nabendu Bhattacharyya, Pranab Kumar Biswas, Madhabi Panpalia. Comparison of IM magnesium sulfate with low dose IV magnesium sulfate regimen for treatment of eclampsia. J Obstet Gynaecol Res. 2009;35(1):119-25.

Shehla Noor, Mussarat Halimi, Nasreen Ruby Faiz, Fouzia Gull, Nasreen Akbar. Magnesium sulphate in the prophylaxis and treatment of eclampsia. J Ayub Med Coll Abbottabad. 2004 Apr-Jun;16(2):50-4.